Mismatch Repair Deficient (dMMR) clinical trials at University of California Health

1 in progress, 0 open to eligible people

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
Sorry, in progress, not accepting new patients
The purpose of this study is to characterize the safety, tolerability, PK, and efficacy of INCB 99280 in combination with ipilimumab in participants with select solid tumors.
at UC Irvine

Last updated: July 2024